Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Yizhou Peng, Li Meng, Xuemei Hu, Zhiqiang Han & Zhenya Hong. (2020) Tuberculosis in Patients with Primary Myelofibrosis During Ruxolitinib Therapy: Case Series and Literature Review. Infection and Drug Resistance 13, pages 3309-3316.
Read now
Read now
Emiko Sakiyama, Yoshiaki Chinen, Taku Tsukamoto, Tomoko Takimoto-Shimomura, Saeko Kuwahara-Ota, Yayoi Matsumura-Kimoto, Yuji Shimura, Tsutomu Kobayashi, Shigeo Horiike & Junya Kuroda. (2020) Tuberculosis Peritonitis During Treatment of Polycythemia Vera with Ruxolitinib. Infection and Drug Resistance 13, pages 1017-1021.
Read now
Read now
Maria Veronica Dioverti, Omar M. Abu Saleh & Aaron J. Tande. (2018) Infectious complications in patients on treatment with Ruxolitinib: case report and review of the literature. Infectious Diseases 50:5, pages 381-387.
Read now
Read now
Palma Manduzio. (2017) Ruxolitinib in myelofibrosis: to be or not to be an immune disruptor. Therapeutics and Clinical Risk Management 13, pages 169-177.
Read now
Read now
Articles from other publishers (19)
Neema Tiwari, Aparajita Singh, Bhupendra Singh, Shailendra Prasad Verma & Anil Kumar Tripathi. (2022) Ruxolitinib and tuberculosis: A case report with brief review. Indian Journal of Tuberculosis 69:3, pages 354-358.
Crossref
Crossref
Wenyue Cao, Yuling Wan, Xingcheng Yang, Wei Huang & Jia Wei. (2022) Pulmonary tuberculosis infection and CMV reactivation following daratumumab treatment in a patient with relapsed plasmablastic lymphoma. Blood Science Publish Ahead of Print.
Crossref
Crossref
Farhan Khalid, Moussab Damlaj, Mohsen AlZahrani, Khadega A. Abuelgasim & Giamal Edin Gmati. (2021) Reactivation of tuberculosis following ruxolitinib therapy for primary myelofibrosis: Case series and literature review. Hematology/Oncology and Stem Cell Therapy 14:3, pages 252-256.
Crossref
Crossref
Lin Du, Yolanda Wong Ying Yip, Him Kwan Ng, Bo Man Ho, Jing-Na He, Sun On Chan, Chi Pui Pang & Wai Kit Chu. (2021) Ruxolitinib Alleviates Uveitis Caused by Salmonella typhimurium Endotoxin. Microorganisms 9:7, pages 1481.
Crossref
Crossref
Marco Santoro, Cristina Rotolo, Vincenzo Accurso, Ilaria Morreale, Salvatrice Mancuso & Sergio Siragusa. (2021) Isolated Nodal TBC Reactivation in a Patient with Post-Thrombocythemia Myelofibrosis Treated with Ruxolitinib: Case Report and Review of the Literature. Chemotherapy 66:3, pages 87-91.
Crossref
Crossref
Parvis Sadjadian, Kai Wille & Martin Griesshammer. (2020) Ruxolitinib-Associated Infections in Polycythemia Vera: Review of the Literature, Clinical Significance, and Recommendations. Cancers 12:11, pages 3132.
Crossref
Crossref
Nobuyasu Hirai, Kei Kasahara, Shingo Yoshihara, Tomoko Nishimura, Keitaro Omori, Yoshihiko Ogawa, Taku Ogawa, Naokuni Hishiya, Yuki Suzuki, Hisakazu Yano, Masahide Yoshikawa & Keiichi Mikasa. (2020) Necessity to screen and treat latent tuberculosis before ruxolitinib treatment—Ruxolitinib-associated disseminated tuberculosis: A case report and literature review. IDCases 21, pages e00892.
Crossref
Crossref
Junshik Hong, Ju Hyun LeeJa Min Byun, Ji Yun LeeYoungil Koh, Dong-Yeop Shin, Jeong-Ok LeeSang Mee Hwang, Hyoung Soo Choi, Inho Kim, Sung-Soo Yoon & Soo-Mee Bang. (2019) Risk of disease transformation and second primary solid tumors in patients with myeloproliferative neoplasms. Blood Advances 3:22, pages 3700-3708.
Crossref
Crossref
Emanuela Sant’Antonio, Massimiliano Bonifacio, Massimo Breccia & Elisa Rumi. (2019) A journey through infectious risk associated with ruxolitinib. British Journal of Haematology 187:3, pages 286-295.
Crossref
Crossref
Georg Maschmeyer, Julien De Greef, Sibylle C. Mellinghoff, Annamaria Nosari, Anne Thiebaut-Bertrand, Anne Bergeron, Tomas Franquet, Nicole M. A. Blijlevens & Johan A. Maertens. (2019) Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL). Leukemia 33:4, pages 844-862.
Crossref
Crossref
Yasuhiro Tsukamoto, Junichi Kiyasu, Mariko Tsuda, Motohiko Ikeda, Motoaki Shiratsuchi, Yoshihiro Ogawa & Yuji Yufu. (2018) Fatal Disseminated Tuberculosis during Treatment with Ruxolitinib Plus Prednisolone in a Patient with Primary Myelofibrosis: A Case Report and Review of the Literature. Internal Medicine 57:9, pages 1297-1300.
Crossref
Crossref
Federico Lussana, Marco Cattaneo, Alessandro Rambaldi & Alessandro Squizzato. (2018) Ruxolitinib-associated infections: A systematic review and meta-analysis. American Journal of Hematology 93:3, pages 339-347.
Crossref
Crossref
Amy Vandiver, Nicholas Girardi, Jihad Alhariri & Luis A. Garza. (2017) Two cases of alopecia areata treated with ruxolitinib: a discussion of ideal dosing and laboratory monitoring. International Journal of Dermatology 56:8, pages 833-835.
Crossref
Crossref
Norio Komatsu, Keita Kirito, Kazuya Shimoda, Takayuki Ishikawa, Kohshi Ohishi, Kazuma Ohyashiki, Naoto Takahashi, Hikaru Okada, Taro Amagasaki, Toshio Yonezu & Koichi Akashi. (2016) Assessing the safety and efficacy of ruxolitinib in a multicenter, open-label study in Japanese patients with myelofibrosis. International Journal of Hematology 105:3, pages 309-317.
Crossref
Crossref
Benoit Branco, David Metsu, Marine Dutertre, Bruno Marchou, Pierre Delobel, Christian Recher & Guillaume Martin-Blondel. (2016) Use of rifampin for treatment of disseminated tuberculosis in a patient with primary myelofibrosis on ruxolitinib. Annals of Hematology 95:7, pages 1207-1209.
Crossref
Crossref
Maheen Z. Abidi, Javeria Haque, Parvathi Varma, Horatiu Olteanu, Guru Subramanian Guru Murthy, Binod Dhakal & Parameswaran Hari. (2016) Reactivation of Pulmonary Tuberculosis following Treatment of Myelofibrosis with Ruxolitinib. Case Reports in Hematology 2016, pages 1-4.
Crossref
Crossref
. (2016) Ruxolitinib. Reactions Weekly 1583:1, pages 967-967.
Crossref
Crossref
Mads Emil Bjørn & Hans Carl Hasselbalch. (2015) The Role of Reactive Oxygen Species in Myelofibrosis and Related Neoplasms. Mediators of Inflammation 2015, pages 1-11.
Crossref
Crossref
Eamon Shamil, David Cunningham, Billy L. K. Wong & Piyush Jani. (2015) Ruxolitinib Associated Tuberculosis Presenting as a Neck Lump. Case Reports in Infectious Diseases 2015, pages 1-3.
Crossref
Crossref